|Bid||0.00 x 1000|
|Ask||0.00 x 1000|
|Day's Range||42.49 - 44.30|
|52 Week Range||30.12 - 69.31|
|Beta (5Y Monthly)||0.96|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||50.99|
Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), today joined a coalition of 37 physician, pharmacy, patient advocacy, health care quality, managed care, and academic associations, companies, and institutions calling upon the U.S. Department of Health and Human Services (HHS) to extend the Center for Medicare & Medicaid Innovation's (CMMI) Part D Enhanced Medication Therapy Management (EMTM) Model currently set to sunset on December 31, 2021.
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC), will hold a conference call and webcast to discuss its second quarter 2021 operating results Friday, August 6, 2021 at 8:30 a.m. EDT. The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Co-Founder and President, Orsula V. Knowlton, PharmD, MBA; and TRHC Chief Financial Officer, Brian W. Adams. The Company's financial results for the second quarter 2021 ending June 30, 2021, will be released after the c